Shows / Oncology Data Advisor
Oncology Data Advisor
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
Episodes
Oncology Data AdvisorUtilizing ctDNA to Assess Survival With Odronextamab for FL and DLBCL: Jon Arnason, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Investigating Talquetamab + Pomalidomide in the MonumenTAL-2 Study: Jeffrey Matous, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Improving QOL in Multiple Myeloma With Bortezomib Dose Reduction: Rahul Banerjee and Gurbakhash Kaur
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Guiding Dietary Choices During Multiple Myeloma Treatment: Richa Parikh, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Improving End-of-Life Care for Patients With AML Receiving Non-Curative Therapy: Richa Thakur, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Coping With Psychological Distress Prior to Hematopoietic Cell Transplantation: Richard Newcomb, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Investigating Odronextamab for R/R FL and DLBCL in the ELM-2 Study: Sabarish Ayyappan, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Exploring Acalabrutinib ± Obinutuzumab for CLL in the ELEVATE-TN Study: Jeff Sharman, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Highlights of Multiple Myeloma Research Presented at ASH 2023: Urvi Shah, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
Oncology Data AdvisorPredicting Immune-Related Adverse Events Through Machine Learning With Dr. Ofer Sharon of OncoHost
In this first episode of Oncology Data Advisor’s new podcast series, “Exploring Artificial Intelligence in Cancer Care,” Dr. Waqas Haque and Dr. Matthew…
- Oncology Data Advisor
Racial and Socioeconomic Disparities in the CLL Community Oncology Setting: Ira Zackon, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Response Patterns of Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Hans Lee, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Real-World Outcomes of Brexucabtagene Autoleucel for Mantle Cell Lymphoma: Swetha Kambhampati, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Investigating Therapies Targeting Cardiovascular Health in MDS: Diego Adrianzen Herrera, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Improving Diversity in Multiple Myeloma Clinical Trials: Craig Cole, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Empowering Patients Through Shared Decision Making in Myelodysplastic Syndromes: Claire Saxton
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Mitigating the Effects of Neighborhood Disadvantage in Acute Myeloid Leukemia: Brittany Ragon, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
CLL Society: Paving the Way For CLL Patients and Survivors With Brian Koffman, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
A Mobile App to Address Sexual Dysfunction in HSCT Survivors: Areej El-Jawahri, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Exploring Results of the IsKia Trial in Newly Diagnosed Multiple Myeloma: Annemiek Broijl, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
Oncology Data AdvisorHighlights From the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD
At the recent San Antonio Breast Cancer Symposium (SABCS), numerous updates were presented which have the potential to improve treatment outcomes for patients…
- Oncology Data Advisor
Reducing Stigmatizing Language in the EMR for More Equitable Care: Alex Boucher, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Expanding Access to Brexucabtagene Autoleucel for Mantle Cell Lymphoma: Andre Goy, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Addressing Ethical Concerns Around Artificial Intelligence in Cancer Care: Andrew Hantel, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Lowering Talquetamab Dosing Intensity to Improve Tolerability: Ajai Chari, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Advancing Inclusion for Blood Donation Systems for Marginalized Groups: Warren Fingrut, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Investigating CD19-Targeted CAR T Cells for Autoimmune Diseases: Fabian Mueller, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Evaluating Outpatient Teclistamab Administration in Multiple Myeloma: Robert Rifkin, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Financial Hardship Experienced During Transplant in Myelodysplastic Syndromes: Christopher Su, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Maintaining Functioning and QOL With Odronextamab for Follicular Lymphoma: Benoit Tessoulin, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many…
- Oncology Data Advisor
Harnessing Machine Learning for MCL Risk Prognostication With Adrian Mosquera, MD, PhD
In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Dr. Adrian Mosquera, Clinical…
- Oncology Data Advisor
New Lung Cancer Screening Guidelines With Brian Whang
Recently, the American Cancer Society recommended new lung cancer screening guidelines to shift the focus from quitting smoking, to helping all individuals who…
- Oncology Data Advisor
TALAPRO-2 (Talazoparib + Enzalutamide) in Prostate Cancer: Stephen Freedland and Neeraj Agarwal
In this interview, Oncology Data Advisor Editorial Board member Dr. Stephen Freedland, Professor of Urology at Cedars-Sinai Medical Center, speaks with Dr…
- Oncology Data Advisor
Implementing Hepatic Artery Infusion Pump Programs With Sepideh Gholami, MD, MAS, FACS, FSSO
Recently, Sepideh Gholami implemented a Hepatic Artery Infusion Pump Program at Northwell Health. In this interview, Dr. Gholami discusses what exactly a…
- Oncology Data Advisor
Enzalutamide Approved for Nonmetastatic CSPC With Biochemical Recurrence: Stephen Freedland, MD
The FDA recently granted approval to enzalutamide (enza) for the treatment of nonmetastatic castration-sensitive prostate cancer (nmCRPC) with biochemical…
Oncology Data AdvisorAdditional Advances in Advanced Prostate Cancer With Tanya Dorff, MD
Recently, Tanya Dorff, MD, Division Chief of the Genitourinary Disease Program at City of Hope, served as faculty for i3 Health's CME/NCPD-approved activity…
- Oncology Data Advisor
Pancreatic Cancer Awareness Month: Improving Early Detection With Joseph Kalis, PharmD, BCOP
This November, Oncology Data Advisor is honoring Pancreatic Cancer Awareness Month and helping to raise awareness about early detection in hopes of improving…
- Oncology Data Advisor
Lung Cancer Awareness Month: Global Perspectives With MedNews Week and Oncology Data Advisor
In this Lung Cancer Awareness Month video, members of Oncology Data Advisor and MedNews Week join forces to share global perspectives regarding treatment…
- Oncology Data Advisor
National Family Caregivers Month With Megan-Claire Chase
During National Family Caregivers Month this November, Oncology Data Advisor is celebrating the caregivers of patients with cancer and advocating for increased…
- Oncology Data Advisor
Great American Smokeout: The Link Between Smoking and Prostate Cancer With Stephen Freedland, MD
In honor of the Great American Smokeout, Oncology Data Advisor sat down with Stephen Freedland, MD, the Director of the Center for Integrated Research in…
- Oncology Data Advisor
National Family Caregivers Month: The Nurse’s Perspective With Maria Badillo, MSN, RN, OCN®, CCRP
During National Family Caregivers Month this November, Oncology Data Advisor is spotlighting not only the caregivers of patients with cancer, but also the…
- Oncology Data Advisor
Venetoclax for Multiple Myeloma in the Post-CANOVA Era: Rahul Banerjee, MD, FACP, and Andrew Yee, MD
At the recent International Myeloma Society (IMS) Annual Meeting in Athens, Greece, results were presented of the CANOVA study of venetoclax for patients with…
Oncology Data AdvisorLung Cancer Awareness Month With Waqas Haque, Samuel Kareff, & Matthew Hadfield
On the first day of Lung Cancer Awareness Month, members of Oncology Data Advisor's Fellows Forum joined forces to share recent research in lung cancer…
- Oncology Data Advisor
Updates on Bispecific Antibodies in Multiple Myeloma From IMS 2023: Rahul Banerjee and Shonali Midha
At this year's International Myeloma Society (IMS) Annual Meeting, Dr. Shonali Midha, Instructor in Medicine at Harvard Medical School, presented real-world…
- Oncology Data Advisor
The Importance of Exercise for Cancer Survivorship With Nagashree Seetharamu
In this interview, Dr. Nagashree Seetharamu, MD, MBBS, a Professor in the Division of Hematology and Medical Oncology in the Department of Medicine at Hofstra…
- Oncology Data Advisor
Creating Educational Opportunities During Fellowship and Beyond With Sam Kareff and Matt Hadfield
This Fellows Forum episode features Dr. Samuel Kareff and Dr. Matthew Hadfield in a discussion about unique ways to create educational opportunities during…
- Oncology Data Advisor
Real-World Use Patterns, Effectiveness, & Tolerability of Sacituzumab Govitecan for TNBC
At this year's European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, Dr. Kevin Kalinsky, Director of the Glenn Family Breast Center at…
- Oncology Data Advisor
Additional Advances in Newly Diagnosed Multiple Myeloma: Interview + Free CPE Podcast
In this interview, Dr. Joseph Kalis, Ambulatory Oncology Clinical Pharmacy Specialist at the University of Colorado Health, speaks with i3 Health and the…
- Oncology Data Advisor
Reframing the Conversation in Metastatic Breast Cancer With Janie Metsker, RN, BSN, CN-BN
For patients with metastatic breast cancer (MBC), Breast Cancer Awareness Month can sometimes be demoralizing in light of pervasive public messaging about…
- Oncology Data Advisor
Tisotumab Vedotin for Metastatic Cervical Cancer: Results From ESMO 2023 With Brian Slomovitz, MD
In this interview, Dr. Brian Slomovitz, Director of Gynecologic Oncology at Mount Sinai Medical Center in Miami Beach, Florida, shares the results of the…
- Oncology Data Advisor
World Cancer Research Day With Samuel Kareff, Maria Badillo, Matthew Hadfield, and Alankrita Taneja
In honor of World Cancer Research Day, members of Oncology Data Advisor's Editorial Board and Fellows Forum joined forces to share their passions for cancer…
- Oncology Data Advisor
Additional Advances in SCLC Radiotherapy With Henry Park, MD, MPH + Free CME/NCPD/CPE Podcast
Recently, Dr. Henry Park, Chief of Thoracic Radiotherapy at Smilow Cancer Network of Yale School of Medicine, served as faculty for i3 Health’s…
- Oncology Data Advisor
Additional Advances in Small Cell Lung Cancer Radiotherapy With Henry Park, MD, MPH
Recently, Dr. Henry Park, Chief of Thoracic Radiotherapy at Smilow Cancer Network of Yale School of Medicine, served as faculty for i3 Health’s…
- Oncology Data Advisor
Exploring Opportunities During Hematology/Oncology Fellowship With Matthew Hadfield and Richa Thakur
In this Oncology Data Advisor Fellows Forum interview, Dr. Matthew Hadfield, Medical Oncology Fellow at Brown University, and Dr. Richa Thakur…
- Oncology Data Advisor
Twice Weekly, Biweekly, Somewhere in Between? Dosing in Myeloma: Rahul Banerjee and Gurbakhash Kaur
In honor of Blood Cancer Awareness Month, Oncology Data Advisor Editorial Board Member Dr. Rahul Banerjee sat down with Gurbakhash Kaur, an Assistant Professor…
- Oncology Data Advisor
Enfortumab Vedotin Plus Pembrolizumab: Results of the EV-302 Trial With Thomas Powles
In this interview, Thomas Powles, MD, MBBS, MRCP, Director of the Barts Cancer Center in London, sat down with Oncology Data Advisor to discuss the results of…
- Oncology Data Advisor
The Rise of Immunotherapy: Considerations to Ensure Optimal Management With Matthew Hadfield, DO
In this Oncology Data Advisor Fellows Forum Interview, Dr. Matthew Hadfield, third-year Hematology/Oncology Fellow at Brown University, shares a comprehensive…
- Oncology Data Advisor
Self-Management Strategies for Peripheral Neuropathy With Connie Visovsky, PhD, RN, ACNP, FAAN
In this interview for Breast Cancer Awareness Month, Dr. Connie Visovsky, Professor and Endowed Chair in Nursing Science at the University of South Florida…
- Oncology Data Advisor
Finding Your Why: Reflecting on the Passion Behind Oncology Nursing With Lauren Ghazal, PhD, FNP-BC
At the 2023 Oncology Nursing Society (ONS) Bridge Conference, Dr. Lauren Ghazal, Assistant Professor in the School of Nursing at the University of Rochester…
- Oncology Data Advisor
Breast Cancer Awareness Month: Debunking Breast Cancer Myths With Jason Mouabbi, MD
In this interview for Breast Cancer Awareness Month, Dr. Jason Mouabbi, Assistant Professor in the Department of Breast Oncology at the University of Texas MD…